BIRC5 and T-cell acute lymphoblastic leukemia: For instance, the NOTCH1-GATA3-MYC-BIRC5 has been characterized in T-cell ALL and acute myeloid leukemia, where it drives initiation and progression by coordinating apoptosis resistance [15], chromatin remodeling [30], and transcriptional control [49].